Affiliations 

  • 1 College of Dentistry, Dar Al Uloom University, Riyadh, Saudi Arabia
  • 2 Faculty of Applied Science, Amran University, Amran, Yemen
  • 3 School of Social Sciences, Main Campus, University Sains Malaysia, Penang, Malaysia
  • 4 Department of Community Health, Faculty of Nursing, Ha'il University, Ha'il, Saudi Arabia
  • 5 Department of Clinical Sciences, Vision College of Medicine, Vision Colleges, Riyadh, Saudi Arabia
Clin Infect Dis, 2022 Nov 14;75(10):1827-1833.
PMID: 35134160 DOI: 10.1093/cid/ciac088

Abstract

BACKGROUND: Vaccine hesitancy and vaccine inequity are 2 major hurdles toward achieving population immunity to coronavirus disease 2019 (COVID-19). Although several studies have been published on vaccine hesitancy among numerous populations, there is inadequate information on any potential correlation between vaccine acceptance and lack of access to vaccines. Our cross-sectional study in a low-income country aimed to fill this gap.

METHODS: We conducted a nation-wide cross-sectional survey among the general population in Yemen, a low-income conflict country. Participants from all provinces in Yemen were included in the study. We evaluated factors that influence agreement to accept a COVID-19 vaccine and any potential correlation between vaccine hesitancy and lack of access to vaccines.

RESULTS: Overall, 50.1% of the 5329 respondents agreed to accept a COVID-19 vaccine. Only 39.9% of participants agreed that they had access to a COVID-19 vaccine, with females indicating lower access than males. Potential determinants of vaccine acceptance included being male, updating self on the development of vaccines against COVID-19, opinion about severity of COVID-19, anxiety about contracting COVID-19, concerns about the safety of COVID-19 vaccines, and lack of access to vaccines.

CONCLUSIONS: Our results indicate that the immediate threat in Yemen toward achieving population immunity is the severe shortage and lack of access to vaccines, rather than vaccine hesitancy.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.